These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 28550675)

  • 1. [Prognostic value of sequencing of radiotherapy and chemotherapy following breast-conserving surgery for patients with breast cancer].
    Zhong QZ; Wang Z; Tang Y; Rong QL; Wang SL; Jin J; Wang WH; Liu YP; Song YW; Fang H; Chen B; Qi SN; Li N; Tang Y; Zhang JH; Li YX
    Zhonghua Zhong Liu Za Zhi; 2017 Apr; 39(4):308-314. PubMed ID: 28550675
    [No Abstract]   [Full Text] [Related]  

  • 2. [Prognosis and risk factors of 1 791 patients with breast cancer treated with breast-conserving surgery based on real-world data].
    Chen SY; Tang Y; Song YW; Wang SL; Jin J; Liu YP; Wang WH; Fang H; Ren H; Sun GY; Wang JY; Jing H; Zhang JH; Liu XF; Yu ZH; Li YX
    Zhonghua Zhong Liu Za Zhi; 2018 Aug; 40(8):619-625. PubMed ID: 30139034
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical characteristics and prognosis of patients with ipsilateral breast tumor recurrence after breast conservation therapy].
    Sun GY; Wang SL; Tang Y; Jin J; Song YW; Liu YP; Wang WH; Fang H; Chen SY; Ren H; Liu XF; Yu ZH; Li YX
    Zhonghua Zhong Liu Za Zhi; 2018 May; 40(5):352-358. PubMed ID: 29860762
    [No Abstract]   [Full Text] [Related]  

  • 4. [The role of postmastectomy radiotherapy in clinical T1-3N1M0 breast cancer patients with pathological negative lymph nodes after neoadjuvant chemotherapy and mastectomy].
    Rong QL; Wang SL; Tang Y; Jin J; Song YW; Wang WH; Liu YP; Fang H; Ren H; Liu XF; Yu ZH; Li YX
    Zhonghua Zhong Liu Za Zhi; 2017 Jun; 39(6):445-452. PubMed ID: 28635235
    [No Abstract]   [Full Text] [Related]  

  • 5. [The influence of molecular classification of breast cancer on the safety of breast-conserving surgery].
    Li Y; Mu L; Ruan YX; Wang YT; Zhang D; Zhou H; Wang X
    Zhonghua Zhong Liu Za Zhi; 2018 May; 40(5):341-346. PubMed ID: 29860760
    [No Abstract]   [Full Text] [Related]  

  • 6. Evaluation of Adjuvant Treatments for T1 N0 M0 Triple-Negative Breast Cancer.
    Zhai Z; Zheng Y; Yao J; Liu Y; Ruan J; Deng Y; Zhou L; Zhao P; Yang S; Hu J; We B; Wu Y; Zhang D; Kang H; Dai Z
    JAMA Netw Open; 2020 Nov; 3(11):e2021881. PubMed ID: 33211105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted Intraoperative Radiotherapy Tumour Bed Boost During Breast Conserving Surgery after Neoadjuvant Chemotherapy in HER2 Positive and Triple Negative Breast Cancer.
    Kolberg HC; Loevey G; Akpolat-Basci L; Stephanou M; Fasching PA; Untch M; Bulsara M; Vaidya JS; Liedtke C
    Rev Recent Clin Trials; 2017; 12(2):93-100. PubMed ID: 28155607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast-conserving surgery is not associated with increased local recurrence in patients with early-stage node-negative triple-negative breast cancer treated with neoadjuvant chemotherapy.
    Krug D; Vladimirova V; Untch M; Kühn T; Schneeweiss A; Denkert C; Ataseven B; Solbach C; Gerber B; Tesch H; Golatta M; Seiler S; Heil J; Nekljudova V; Holtschmidt J; Loibl S
    Breast; 2024 Apr; 74():103701. PubMed ID: 38422624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical outcomes according to molecular subtypes in stage II-III breast cancer patients treated with neoadjuvant chemotherapy followed by surgery and radiotherapy.
    Kim H; Park W; Huh SJ; Choi DH; Noh JM; Im YH; Ahn JS; Park YH; Nam SJ; Kim SW; Lee JE; Cho EY
    Asia Pac J Clin Oncol; 2017 Aug; 13(4):329-336. PubMed ID: 27869361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Postmastectomy radiotherapy for early breast cancer].
    Wang S; Li Y; Yu Z
    Zhonghua Zhong Liu Za Zhi; 2002 Jan; 24(1):68-70. PubMed ID: 11977644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of the time between surgery and radiotherapy on local recurrence in patients with lymph node-positive, early-stage, invasive breast carcinoma undergoing breast-conserving surgery: results of the French Adjuvant Study Group.
    Benchalal M; Le Prisé E; de Lafontan B; Berton-Rigaud D; Belkacemi Y; Romestaing P; Peignaux K; Courdi A; Monnier A; Montcuquet P; Goudier MJ; Marchal C; Chollet P; Abadie-Lacourtoisie S; Datchary J; Veyret C; Kerbrat P
    Cancer; 2005 Jul; 104(2):240-50. PubMed ID: 15948160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 10 year survival after breast-conserving surgery plus radiotherapy compared with mastectomy in early breast cancer in the Netherlands: a population-based study.
    van Maaren MC; de Munck L; de Bock GH; Jobsen JJ; van Dalen T; Linn SC; Poortmans P; Strobbe LJA; Siesling S
    Lancet Oncol; 2016 Aug; 17(8):1158-1170. PubMed ID: 27344114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical activity of adjuvant cytokine-induced killer cell immunotherapy in patients with post-mastectomy triple-negative breast cancer.
    Pan K; Guan XX; Li YQ; Zhao JJ; Li JJ; Qiu HJ; Weng DS; Wang QJ; Liu Q; Huang LX; He J; Chen SP; Ke ML; Zeng YX; Xia JC
    Clin Cancer Res; 2014 Jun; 20(11):3003-11. PubMed ID: 24668644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival and local control rates of triple-negative breast cancer patients treated with boost-IOERT during breast-conserving surgery.
    Fastner G; Hauser-Kronberger C; Moder A; Reitsamer R; Zehentmayr F; Kopp P; Fussl C; Fischer T; Deutschmann H; Sedlmayer F
    Strahlenther Onkol; 2016 Jan; 192(1):1-7. PubMed ID: 26403912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Risk-adapted postmastectomy radiotherapy based on local-regional recurrence for T1-2N1M0 breast Cancer].
    Li M; Wang SL; Fang H; Tang Y; Chen B; Qi SN; Song YW; Liu YP; Lu NN; Li N; Tang Y; Ren H; Jin J; Li YX
    Zhonghua Zhong Liu Za Zhi; 2017 Nov; 39(11):841-849. PubMed ID: 29151291
    [No Abstract]   [Full Text] [Related]  

  • 16. Interval between breast-conserving surgery and start of radiation therapy in early-stage breast cancer is not predictive of local recurrence: a single-institution experience.
    Barbieri V; Sanpaolo P; Genovesi D
    Clin Breast Cancer; 2011 Apr; 11(2):114-20. PubMed ID: 21569997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical features and prognosis of patients with first-episode liver metastasis of different molecular subtypes of breast cancer].
    Wu SY; Tan Y; Guan YS
    Zhonghua Gan Zang Bing Za Zhi; 2016 Jun; 24(6):422-8. PubMed ID: 27465945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Timing of radiotherapy in breast cancer conserving treatment.
    Ruo Redda MG; Verna R; Guarneri A; Sannazzari GL
    Cancer Treat Rev; 2002 Feb; 28(1):5-10. PubMed ID: 12027411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of radiotherapy after breast-conserving surgery in elderly patients with early breast cancer according to the AJCC 8th Edition Breast Cancer Staging System in Japan.
    Tang L; Ma Z; Ishikawa Y; Matsushita H; Ishida T; Jingu K
    Breast Cancer; 2021 Mar; 28(2):465-470. PubMed ID: 33141399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Equivalent Survival With Mastectomy or Breast-conserving Surgery Plus Radiation in Young Women Aged < 40 Years With Early-Stage Breast Cancer: A National Registry-based Stage-by-Stage Comparison.
    Ye JC; Yan W; Christos PJ; Nori D; Ravi A
    Clin Breast Cancer; 2015 Oct; 15(5):390-7. PubMed ID: 25957740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.